Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes

Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.

Deborah J. Newton, R W Wang, Anthony Y.H. Lu · Drug Metabolism and Disposition · 1995 · 606 citations

Medicine, Pharmacokinetics, Pharmacology +17

Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9

Sandra Baldwin, J. C. Bloomer, Graeme Smith et al. · Xenobiotica · 1995 · 298 citations

Medicine, Biochemistry, Pharmacology +17

Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of<i>in vitro</i>metabolism using cDNA-expressed human P450s and human liver microsomes

Satoshi Ono, T. Hatanaka, Hiroshi Hotta et al. · Xenobiotica · 1996 · 273 citations

Medicine, Biochemistry, Pharmacology +17

Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.

George Schwab, Judy L. Raucy, Eric F. Johnson · Molecular Pharmacology · 1988 · 145 citations

Life Sciences, Biochemistry, Pharmacology +17

Hashish—VII

Yehiel Gaoni, Raphael Mechoulam · Tetrahedron · 1966 · 122 citations